ホーム › 胆管癌（胆管細胞癌） › カリフォルニア州
カリフォルニア州における胆管癌（胆管細胞癌）の臨床試験
カリフォルニア州内の拠点で、胆管癌（胆管細胞癌）に関する20件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06840886A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- City of Hope (Site 107), Duarte
- University of California at Irvine (Site 101), Orange
- UCLA Medical Center (Site 117), Santa Monica
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START Los Angeles, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Stanford University, Palo Alto
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05732831Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中
18歳以上 · 全性別 · 2026/08/31更新 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07619313Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
被験者募集中第4相
18歳以上 · 全性別 · 2026/08/11更新 · NCT07486713Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
- City of Hope Medical Center, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05285358A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
- USC Norris Comprehensive Cancer Center, Los Angeles
- LACN Aneheim Flagship Office, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05874414A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07337525A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- City of Hope Nat Medical Ctr, Duarte
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/07更新 · NCT07224750An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- City of Hope Medical Center, Duarte
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/07更新 · NCT06342414A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/02更新 · NCT07169734Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
- University of California, Davis Comprehensive Cancer Center, Sacramento
被験者募集中
18歳以上 · 全性別 · 2026/07/02更新 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347A Study of MGC028 in Participants With Advanced Solid Tumors
- UCSF - Helen Diller Family Cancer Center, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/27更新 · NCT06723236REGULUS: MRI-guided Adaptive SABR for Liver Cancers
- Stanford University, Palo Alto
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/09更新 · NCT07223307SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。